Preoperative workup in the assessment of adrenal incidentalomas: outcome from 282 consecutive laparoscopic adrenalectomies

BMC Surgery

Annamaria Colao²  Rosario Pivonello²  Bernadette Biondi²  Paolo Bianco⁴  Antonietta Palazzo¹  Luigi Santini¹  Annunziato Tricarico⁵  Maurizio De Palma³  Giulio Belli⁶  Francesco Corcione⁷  Marco Milone⁴  Giovanni Conzo¹  Mario Musella⁴ 

[1] General and Endocrine Surgery, Second University “SUN”, Naples, Italy;Endocrinology, “Federico II” University, Naples, Italy;General and Endocrine Surgery, AORN “A. Cardarelli” Hospital, Naples, Italy;General and Emergency Surgery, “Federico II” University, Naples, Italy;General and Emergency Surgery, AORN “A. Cardarelli” Hospital, Naples, Italy;General Surgery, “S. Maria di Loreto Nuovo” Hospital, Naples, Italy;General and Laparoscopic Surgery, AORN “Monaldi” Hospital, Naples, Italy

关键词: Guidelines;    Pheochromocytoma;    Preoperative workup;    Adrenocortical cancer;    Incidentaloma;    Laparoscopic adrenalectomy;   

Others  :  866896
DOI  :  10.1186/1471-2482-13-57

 received in 2013-05-21, accepted in 2013-11-21,  发布年份 2013

【 摘 要 】

Background

To confirm the efficacy of preoperative workup, the authors analyse the results of a multicentre study in a surgical series of patients diagnosed with an adrenal incidentaloma.

Methods

The retrospective review of a prospectively collected database was conducted. The data was obtained by six surgical units operating in the Campania Region, Italy. Five-hundred and six (506) adrenalectomies performed between 1993 and 2011 on 498 patients were analysed. Final histology in patients with a preoperative diagnosis of incidentaloma and studied according to guidelines (230/282 patients group A) was compared with final histology coming from patients presenting the same preoperative diagnosis but studied not according to guidelines (52/282 patients group B).

Results

In group A preoperative diagnosis was confirmed at final histology in 76/81 (93.8%) cases of subclinical functioning lesions presenting as an incidentaloma. The preoperative detection of pheochromocytoma and primary adrenocortical cancer (ACC) reached 91.6% and 84.6% respectively. In group B conversion rate to open surgery was higher than in group A (p = 0.02). One pheochromocytoma was missed at preoperative diagnosis whereas one ACC smaller than 4 centimetres (cm) and coming from an incidental lesion was discovered. In both groups a significant association between increasing dimensions of incidentaloma and cancer has been observed (p = 0.001).

Conclusions

This surgical series confirm the high efficacy of suggested guidelines. A significant preoperative detection rate of adrenal lesions presenting as incidentaloma is observed. The unnecessary number of adrenalectomies performed in understudied patients, causing higher morbidity, was not associated to a higher detection rate of primary adrenocortical cancer.

【 授权许可】

   
2013 Musella et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Bittner JB, Brunt ML: Evaluation and management of adrenal incidentaloma. J Surg Oncol 2012, 106:557-564.
• [2]Kanthan R, Senger JL, Kanthan S: Three uncommon adrenal incidentalomas: a 13-year surgical pathology review. World J Surg Oncol 2012, 10:64. BioMed Central Full Text
• [3]Mazzaglia PJ, Monchik JM: Limited value of adrenal biopsy in the evaluation of adrenal neoplasm: a decade of experience. Arch Surg 2009, 144:465-470.
• [4]NIH State-of-the-Science Statement on management of the clinically inapparent adrenal mass (“incidentaloma”) NIH Consens State Sci Statements 2002, 19(2):1-25.
• [5]Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al.: The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 2009, 15(Suppl 1):1-20.
• [6]Smith CD, Weber CJ, Amerson JR: Laparoscopic adrenalectomy: new gold standard. World J Surg 1999, 23:389-396.
• [7]Mantero F, Terzolo M, Arnaldi G, et al.: A survey on adrenal incidentaloma in Italy. Study group on adrenal tumours of the Italian society of endocrinology. J Clin Endocrinol Metab 2000, 85:637-644.
• [8]Grumbach MM, Biller BM, Braunstein GD, et al.: Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 2003, 138:424-429.
• [9]Shen WT, Sturgeon C, Duh QY: From incidentaloma to Adrenocortical carcinoma: the surgical management of adrenal tumors. J Surg Oncol 2005, 89:186-192.
• [10]Mitchell IC, Nwariaku FE: Adrenal masses in the cancer patient: surveillance or excision. Oncologist 2007, 12:168-174.
• [11]Miccoli P, Raffaelli M, Berti P, et al.: Adrenal surgery before and after the introduction of laparoscopic adrenalectomy. Br J Surg 2002, 89:779-782.
• [12]Saunders BD, Wainess RM, Dimick JB, et al.: Trends in utilization of adrenalectomy in the United States: have indications changed? World J Surg 2004, 28:1169-1175.
• [13]Conzo G, Tricarico A, Belli G, et al.: Adrenal incidentalomas in the laparoscopic era: the role of a correct surgical indication. Observations from 255 consecutive adrenalectomies in an Italian series. Can J Surg 2009, 52(6):E281-E285.
• [14]Boland GWL, Blake MA, Hahn PF, Mayo-Smith WW: Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 2008, 249:756-775.
• [15]Hamrahian AH, Ioachimescu AG, Remer EM, et al.: Clinical utility of noncontrast computed tomography atten- uation value (Hounsfield units) to differentiate adrenal ade- nomas/hyperplasias from nonadenomas: cleveland clinic experience. J Clin Endocrinol Metab 2005, 90:871-877.
• [16]Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V, Zini M, Borretta G, Papini E, Garofalo P, Allolio B, Dupas B, Mantero F, Tabarin A: AME position statement on adrenal incidentaloma. Eur J Endocrinol 2011, 164:851-870.
• [17]De Leo M, Cozzolino A, Colao A, Pivonello R: Subclinical Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab 2012, 26:497-505.
• [18]Conzo G, Musella M, Corcione F, De Palma M, Ferraro F, Palazzo A, Napolitano S, Milone M, Pasquali D, Sinisi AA, Colantuoni V, Santini L: Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series. Int J Surg 2013, 11:152-156.
• [19]Grogan RH, Mitmaker E, Vriens MR, et al.: Adrenal incidentaloma: does an adequate workup rule out surprises? Surgery 2010, 148:392-397.
• [20]Lumachi F, Basso SM, Borsato S, Tregnaghi A, Zucchetta P, Marzola MC, Cecchin D, Bui F, Favia G: Role and cost-effectiveness of adrenal imaging and image guided FNA cytology in the management of incidentally discovered adrenal tumours. Anticancer Res 2005, 25:4559-4562.
• [21]Mazzaglia PJ, Vezeridis MP: Laparoscopic adrenalectomy: balancing the operative indications with the technical advances. J Surg Oncol 2010, 101:739-744.
• [22]Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E: Risk assesment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg 2006, 202:423-430.
• [23]Lau H, Lo CY, Lam KY: Surgical implications of underestimation of adrenal tumor size by computed tomography. Br J Surg 1999, 186:385-387.
• [24]Assalia A, Gagner M: Laparoscopic adrenalectomy. Br J Surg 2004, 91:1259-1274.
• [25]O’Neill CJ, Spence A, Logan B, Suliburk JW, Soon PS, Learoyd DL, Sidhu SB, Sywak MS: Adrenal Incidentalomas: risk of adrenocortical carcinoma and clinical outcomes. J Surg Oncol 2010, 102:450-453.
• [26]Kasperlik-Zaluska AA, Otto M, Cichocki A, et al.: Incidentally discovered adrenal tumors: a lesson from observation of 1444 patients. Horm Metab Res 2008, 40:338-341.
• [27]Wang ST, Cheung K, Sanziana AR, Sosa JA: A cost-effectiveness analysis of adrenalectomy for nonfunctional adrenal incidentalomas: Is there a size threshold for resection? Surgery 2012, 152:1125-1132.
• [28]Cawood TJ, Hunt PJ, O’Shea D, Cole D, Soule S: Recommended evaluation of adrenal incidentalomas is costly, has high false positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant, time for a rethink? Eur J Endocrinol 2009, 161:513-527.